Welcome to the 2nd Cell Therapy for Autoimmune Disease Summit
Following the latest data revealing the promise of cell therapies for lupus, all eyes are on how to pave the way to develop the first curative treatments for autoimmune patients
The 2nd Cell Therapy for Autoimmune Disease Summit returns to Philadelphia bigger and better after last year’s explosive debut as the only meeting covering every aspect of bringing cell therapies to the autoimmune space. This is your unmissable opportunity to learn the A-Zs of accelerating your candidates to be the first in the market and finally bring the cure for an autoimmune indication.
Join 30+ trailblazers including Cartesian Therapeutics, Bristol Myers Squibb, the University of Pennsylvania, ImmPACT Bio and more as they unveil their latest clinical updates, next-generation candidates, novel antigen targets, and translational biomarkers to turbocharge the development of cell therapies for autoimmune disease.
With a brand new 2 tracked agenda, hear in-depth presentations across preclinical development versus clinical strategy to strategically gain the insight your team needs to boost your candidates among industry pioneers. This year will be the biggest edition of this meeting yet as this community expands to grasp every opportunity available.
World-Class Speaker Faculty Includes:
David Porter
Director - Cell Therapy & Transplant Blood and Marrow Transplantation
Penn Medicine/ University of Pennsylvania
Previously Attending Companies Include:
Our Partners:
“The initial meeting last year was outstanding as a way to keep abreast of this fast-moving space in a very collegial environment”
Greg Deener, Chief Executive Officer, iCell Gene Therapeutics, 2024 Speaker